Tag: audit trail

Designing a DI-Aware Change Control Template for GxP Systems Step-by-Step Guide to Designing a Data Integrity-Aware Change Control Template for GxP Systems In the pharmaceutical industry, ensuring data integrity throughout manufacturing, clinical, and regulatory processes is paramount to patient safety and regulatory compliance. With global regulatory agencies emphasizing strict adherence to principles such as ALCOA+…

Read More “Designing a DI-Aware Change Control Template for GxP Systems” »

Ensuring DI in GMP Training Systems and E-Learning Platforms Ensuring Data Integrity in GMP Training Systems and E-Learning Platforms: A Step-by-Step Tutorial Guide In the context of pharmaceutical manufacturing and compliance, data integrity (DI) is paramount across all GxP systems, including GMP training systems and e-learning platforms. The accuracy, reliability, and security of training records…

Read More “Ensuring DI in GMP Training Systems and E-Learning Platforms” »

Ensuring DI in GMP Training Systems and E-Learning Platforms Practical Guide to Ensuring Data Integrity in GMP Training Systems and E-Learning Platforms The pharmaceutical industry is held to the highest standards regarding data management, with robust compliance expectations for data integrity embedded in various regulations including 21 CFR Part 11, Annex 11 of the EU…

Read More “Ensuring DI in GMP Training Systems and E-Learning Platforms” »

Managing DI in Deviations, CAPA, Complaints and Change Control Systems Comprehensive Step-by-Step Guide to Managing Data Integrity in Deviations, CAPA, Complaints, and Change Control Systems Effective management of data integrity within pharmaceutical Quality Management Systems (QMS) is essential to ensure product quality, patient safety, and regulatory compliance. This is especially critical in the context of…

Read More “Managing DI in Deviations, CAPA, Complaints and Change Control Systems” »

Reconstructing Historical Studies When Legacy Data Integrity Issues Are Found Step-by-Step Tutorial for Reconstructing Historical Studies Amid Legacy Data Integrity Issues Pharmaceutical manufacturers and clinical research organizations face significant challenges when discovering data integrity issues in legacy studies. Such historic studies may underpin regulatory submissions, product approvals, or postmarket surveillance activities. Correctly addressing data integrity…

Read More “Reconstructing Historical Studies When Legacy Data Integrity Issues Are Found” »

Communicating DI Risks and Remediation Progress Transparently to Regulators Step-by-Step Guide to Communicating Data Integrity Risks and Remediation Progress Transparently to Regulators For pharmaceutical manufacturers operating under stringent regulatory environments in the US, UK, and EU, the transparent communication of data integrity (DI) risks and remediation progress with regulatory authorities is fundamental to maintaining trust…

Read More “Communicating DI Risks and Remediation Progress Transparently to Regulators” »

Creating Data Integrity “Golden Rules” Pocket Guides for GMP Personnel Step-by-Step Guide: Creating Data Integrity “Golden Rules” Pocket Guides for GMP Personnel Data integrity remains a cornerstone of pharmaceutical Good Manufacturing Practice (GMP) compliance, directly impacting patient safety, product quality, and regulatory trust. Ensuring that pharma personnel fully understand and consistently apply data integrity principles—particularly…

Read More “Creating Data Integrity “Golden Rules” Pocket Guides for GMP Personnel” »

Conducting DI-Focused Gemba Walks in Production, Warehouse and QC Labs Step-by-Step Guide to Conducting Data Integrity-Focused Gemba Walks in Pharma Operations Data integrity remains a cornerstone of pharmaceutical Good Manufacturing Practice (GMP), ensuring that pharmaceutical products are safe, effective, and compliant with regulatory expectations in the US, UK, and EU. Embedded within the FDA’s 21…

Read More “Conducting DI-Focused Gemba Walks in Production, Warehouse and QC Labs” »

Ensuring DI in Real-Time Release Testing and PAT Implementations Comprehensive Step-by-Step Guide to Ensuring Data Integrity in Real-Time Release Testing and PAT Implementations In the pharmaceutical industry, data integrity plays a pivotal role in ensuring product quality and regulatory compliance, particularly during critical processes such as Real-Time Release Testing (RTRT) and Process Analytical Technology (PAT)…

Read More “Ensuring DI in Real-Time Release Testing and PAT Implementations” »

Handling Data From Temporary or Loaned Instruments Without Losing Traceability Ensuring Data Integrity When Using Temporary or Loaned Pharmaceutical Instruments Pharmaceutical manufacturers frequently encounter scenarios where temporary or loaned instruments are integrated into their manufacturing or quality control processes. While these instruments provide operational flexibility, they also pose significant challenges related to data integrity, traceability,…

Read More “Handling Data From Temporary or Loaned Instruments Without Losing Traceability” »